DK382185D0 - Umaettede 10-substituerede steroider samt fremgangsmaade til deres fremstilling - Google Patents

Umaettede 10-substituerede steroider samt fremgangsmaade til deres fremstilling

Info

Publication number: DK382185D0
Authority: DK; Denmark
Prior art keywords: preparation; unsatured; procedures; substituted steroids; trichloroethoxycarbonylamino
Prior art date: 1984-08-24

Application number

DK382185A

Other languages

English (en)

Other versions

DK382185A (da

DK168538B1 (da

Inventor

Martine Moguilewsky

Anne-Marie Moura

Lucien Nedelec

Vesperto Torelli

Original Assignee

Roussel Uclaf

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1984-08-24

Filing date

1985-08-23

Publication date

1985-08-23

1985-08-23 Application filed by Roussel Uclaf filed Critical Roussel Uclaf

1985-08-23 Publication of DK382185D0 publication Critical patent/DK382185D0/da

1986-02-25 Publication of DK382185A publication Critical patent/DK382185A/da

1994-04-18 Application granted granted Critical

1994-04-18 Publication of DK168538B1 publication Critical patent/DK168538B1/da

Links

238000000034 method Methods 0.000 title abstract 2
150000003431 steroids Chemical class 0.000 title 1
-1 tritylamino Chemical group 0.000 abstract 2
125000003342 alkenyl group Chemical group 0.000 abstract 1
125000000304 alkynyl group Chemical group 0.000 abstract 1
125000003710 aryl alkyl group Chemical group 0.000 abstract 1
125000003118 aryl group Chemical group 0.000 abstract 1
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
125000004663 dialkyl amino group Chemical group 0.000 abstract 1
125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 abstract 1
229910052736 halogen Inorganic materials 0.000 abstract 1
150000002367 halogens Chemical class 0.000 abstract 1
125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
239000013067 intermediate product Substances 0.000 abstract 1
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
125000000547 substituted alkyl group Chemical group 0.000 abstract 1
125000004213 tert-butoxy group Chemical group [H]C([H])([H])C(O*)(C([H])([H])[H])C([H])([H])[H] 0.000 abstract 1
125000001412 tetrahydropyranyl group Chemical group 0.000 abstract 1
125000004665 trialkylsilyl group Chemical group 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0003—Androstane derivatives
- C07J1/0011—Androstane derivatives substituted in position 17 by a keto group
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0003—Androstane derivatives
- C07J1/0018—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
- C07J1/0022—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0003—Androstane derivatives
- C07J1/0033—Androstane derivatives substituted in position 17 alfa and 17 beta
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0003—Androstane derivatives
- C07J1/0033—Androstane derivatives substituted in position 17 alfa and 17 beta
- C07J1/0037—Androstane derivatives substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being a saturated hydrocarbon group
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0003—Androstane derivatives
- C07J1/0033—Androstane derivatives substituted in position 17 alfa and 17 beta
- C07J1/004—Androstane derivatives substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
- C07J1/0044—Alkenyl derivatives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J21/001—Lactones
- C07J21/003—Lactones at position 17
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J21/005—Ketals
- C07J21/006—Ketals at position 3
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
- C07J31/003—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring the S atom directly linked to a ring carbon atom of the cyclopenta(a)hydrophenanthrene skeleton
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
- C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J33/00—Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J33/005—Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton spiro-condensed
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0038—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 with an androstane skeleton, including 18- or 19-substituted derivatives, 18-nor derivatives and also derivatives where position 17-beta is substituted by a carbon atom not directly bonded to a further carbon atom and not being part of an amide group
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0094—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 containing nitrile radicals, including thiocyanide radicals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J43/006—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton spiro-condensed
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
- C07J53/002—Carbocyclic rings fused
- C07J53/004—3 membered carbocyclic rings
- C07J53/007—3 membered carbocyclic rings in position 6-7

Landscapes

Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Cardiology (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Heart & Thoracic Surgery (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Toxicology (AREA)
General Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Hospice & Palliative Care (AREA)
Steroid Compounds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Separation By Low-Temperature Treatments (AREA)
Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

DK382185A 1984-08-24 1985-08-23 Steroider, som i 10-stillingen er substitueret med en gruppe indeholdende en dobbelt eller tredobbelt binding, fremgangsmåde til deres fremstilling samt farmaceutiske præparater indeholdende forbindelserne DK168538B1 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR8413189		1984-08-24
FR8413189A FR2569408B1 (fr)	1984-08-24	1984-08-24	Nouveaux steroides substitues en position 10 par un radical comportant une double ou triple liaison, leur procede de preparation, leur application comme medicaments, les compositions pharmaceutiques les renfermant

Publications (3)

Publication Number	Publication Date
DK382185D0 true DK382185D0 (da)	1985-08-23
DK382185A DK382185A (da)	1986-02-25
DK168538B1 DK168538B1 (da)	1994-04-18

Family

ID=9307209

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK382185A DK168538B1 (da)	1984-08-24	1985-08-23	Steroider, som i 10-stillingen er substitueret med en gruppe indeholdende en dobbelt eller tredobbelt binding, fremgangsmåde til deres fremstilling samt farmaceutiske præparater indeholdende forbindelserne

Country Status (21)

Country	Link
US (1)	US4701449A (da)
EP (2)	EP0176399B1 (da)
JP (1)	JPH0649717B2 (da)
KR (1)	KR940008596B1 (da)
CN (1)	CN1029683C (da)
AT (2)	ATE78826T1 (da)
AU (1)	AU580086B2 (da)
CA (1)	CA1260459A (da)
DE (2)	DE3569739D1 (da)
DK (1)	DK168538B1 (da)
ES (1)	ES8604988A1 (da)
FI (1)	FI82699C (da)
FR (1)	FR2569408B1 (da)
GR (1)	GR852037B (da)
HU (1)	HU194276B (da)
IE (1)	IE64675B1 (da)
IL (1)	IL76096A (da)
MX (1)	MX159930A (da)
PT (1)	PT81020B (da)
SU (1)	SU1470198A3 (da)
ZA (1)	ZA856427B (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2576025B1 (fr) *	1985-01-14	1987-01-23	Roussel Uclaf	Nouveaux steroides substitues en position 10, leur procede et les intermediaires de preparation, leur application comme medicaments, les compositions pharmaceutiques les contenant
FR2594829B1 (fr) *	1986-02-24	1988-06-03	Roussel Uclaf	Nouveaux steroides 9 (11) satures substitues en position 10 par un radical comportant une triple liaison, leur procede de preparation, leur application comme medicaments, les compositions pharmaceutiques les renfermant
WO1990002781A1 (en) *	1988-09-16	1990-03-22	Lithium Corporation Of America	Thermally stable, reactive organometallic compositions containing copper
US5100575A (en) *	1989-09-08	1992-03-31	Fmc Corporation	Thermally stable, reactive organometallic compositions containing copper
ATE473759T1 (de)	1998-05-22	2010-07-15	Univ Leland Stanford Junior	Bifunktionelle moleküle sowie darauf basierende therapien.
CN102379684B (zh)	2005-04-28	2014-11-19	普罗透斯数字保健公司	药物信息系统
US9062126B2 (en)	2005-09-16	2015-06-23	Raptor Pharmaceuticals Inc.	Compositions comprising receptor-associated protein (RAP) variants specific for CR-containing proteins and uses thereof
FR2917975B1 (fr) *	2007-06-26	2009-10-16	Ceva Sante Animale Sa	Compositions et traitement de l'insuffisance cardiaque chez les animaux mammiferes non humains
US20090270356A1 (en) *	2008-04-28	2009-10-29	Ceva Sante Animale Sa	Compositions and treatments of heart failure in non-human mammal animals
EP2398500B1 (en)	2009-02-20	2019-03-13	2-BBB Medicines B.V.	Glutathione-based drug delivery system
ES2942923T3 (es)	2009-05-06	2023-06-07	Laboratory Skin Care Inc	Composiciones de administración dérmica que comprenden complejos de agente activo-partículas de fosfato de calcio y métodos de uso de las mismas
CN103145785B (zh) *	2013-03-19	2016-03-02	浙江仙居仙乐药业有限公司	一种醋酸环丙孕酮脱氢物的合成方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3102127A (en) *	1962-06-12	1963-08-27	Syntex Corp	19-methylene-androstane derivatives
US3218316A (en) *	1963-08-26	1965-11-16	Syntex Corp	10beta-ethynyl-19-norandrostane derivatives
US3275622A (en) *	1963-12-18	1966-09-27	Syntex Corp	19-alkylidene-delta4-3, 20-keto pregnanes
FR1519387A (fr) *	1966-04-20	1968-03-29	Hoffmann La Roche	Procédé pour la préparation de 19-alcényl-stéroïdes
FR2344286A1 (fr) *	1976-03-16	1977-10-14	Roussel Uclaf	Nouveaux derives 17-spirosultines, les g-hydroxy acides correspondants, leur procede de preparation et leur application comme medicament
FR2462445A1 (fr) *	1979-07-31	1981-02-13	Roussel Uclaf	Nouveaux derives 17-/(hydroxymethyl) (formamido) methylene/steroides, leur procede de preparation et leur application a l'introduction de la chaine laterale hydroxyacetyle
HU179980B (en) *	1979-12-28	1983-01-28	Gyogyszerkutato Intezet	Process for preparing substituted steroid-spiro-oxazolidinone derivatives
US4322416A (en) *	1980-06-27	1982-03-30	Merrell Dow Pharmaceuticals Inc.	10-Alkynyl steroids

1984
- 1984-08-24 FR FR8413189A patent/FR2569408B1/fr not_active Expired
1985
- 1985-08-15 IL IL76096A patent/IL76096A/xx not_active IP Right Cessation
- 1985-08-22 EP EP85401672A patent/EP0176399B1/fr not_active Expired
- 1985-08-22 DE DE8585401672T patent/DE3569739D1/de not_active Expired
- 1985-08-22 EP EP88117295A patent/EP0313960B1/fr not_active Expired - Lifetime
- 1985-08-22 AT AT88117295T patent/ATE78826T1/de not_active IP Right Cessation
- 1985-08-22 AT AT85401672T patent/ATE42561T1/de not_active IP Right Cessation
- 1985-08-22 DE DE8888117295T patent/DE3586427T2/de not_active Expired - Fee Related
- 1985-08-22 GR GR852037A patent/GR852037B/el unknown
- 1985-08-22 HU HU853201A patent/HU194276B/hu not_active IP Right Cessation
- 1985-08-23 US US06/768,867 patent/US4701449A/en not_active Expired - Lifetime
- 1985-08-23 DK DK382185A patent/DK168538B1/da not_active IP Right Cessation
- 1985-08-23 FI FI853254A patent/FI82699C/fi not_active IP Right Cessation
- 1985-08-23 CA CA000489345A patent/CA1260459A/fr not_active Expired
- 1985-08-23 JP JP60184359A patent/JPH0649717B2/ja not_active Expired - Fee Related
- 1985-08-23 IE IE207585A patent/IE64675B1/en not_active IP Right Cessation
- 1985-08-23 AU AU46625/85A patent/AU580086B2/en not_active Ceased
- 1985-08-23 ZA ZA856427A patent/ZA856427B/xx unknown
- 1985-08-23 SU SU3952445A patent/SU1470198A3/ru active
- 1985-08-23 PT PT81020A patent/PT81020B/pt not_active IP Right Cessation
- 1985-08-23 ES ES546372A patent/ES8604988A1/es not_active Expired
- 1985-08-24 KR KR1019850006172A patent/KR940008596B1/ko not_active Expired - Fee Related
- 1985-08-26 MX MX8656A patent/MX159930A/es unknown
- 1985-09-18 CN CN85106995A patent/CN1029683C/zh not_active Expired - Lifetime

Also Published As

Publication number	Publication date
HU194276B (en)	1988-01-28
CN85106995A (zh)	1987-04-01
US4701449A (en)	1987-10-20
ATE42561T1 (de)	1989-05-15
CN1029683C (zh)	1995-09-06
EP0313960B1 (fr)	1992-07-29
KR860001824A (ko)	1986-03-22
IE852075L (en)	1986-02-24
FR2569408B1 (fr)	1986-10-03
DE3586427D1 (de)	1992-09-03
DK382185A (da)	1986-02-25
EP0313960A1 (fr)	1989-05-03
FR2569408A1 (fr)	1986-02-28
AU4662585A (en)	1986-02-27
ATE78826T1 (de)	1992-08-15
ZA856427B (en)	1986-10-29
JPS6176499A (ja)	1986-04-18
FI82699B (fi)	1990-12-31
KR940008596B1 (ko)	1994-09-24
DK168538B1 (da)	1994-04-18
SU1470198A3 (ru)	1989-03-30
EP0176399B1 (fr)	1989-04-26
FI82699C (fi)	1991-04-10
FI853254A0 (fi)	1985-08-23
ES8604988A1 (es)	1986-03-01
ES546372A0 (es)	1986-03-01
AU580086B2 (en)	1988-12-22
EP0176399A1 (fr)	1986-04-02
PT81020B (pt)	1987-12-30
CA1260459A (fr)	1989-09-26
HUT39461A (en)	1986-09-29
DE3586427T2 (de)	1993-01-07
FI853254L (fi)	1986-02-25
DE3569739D1 (en)	1989-06-01
GR852037B (da)	1985-12-18
MX159930A (es)	1989-10-06
IE64675B1 (en)	1995-08-23
JPH0649717B2 (ja)	1994-06-29
IL76096A0 (en)	1985-12-31
IL76096A (en)	1989-09-10
PT81020A (fr)	1985-09-01

Legal Events

Date	Code	Title	Description
1994-04-18	B1	Patent granted (law 1993)
2004-07-12	PBP	Patent lapsed	Country of ref document: DK

Publication	Publication Date	Title
IT7851783A0 (it)	1978-11-06	Sistema per l'applicazione di rivetti senza testa
DK382185A (da)	1986-02-25	Umaettede 10-substituerede steroider samt fremgangsmaade til deres fremstilling
ES2057899T3 (es)	1994-10-16	Procedimiento para la preparacion estereoselectiva de derivados de la fenilisoserina.
FI903153A0 (fi)	1990-06-21	11b-aryl-4-estrener, foerfarande foer deras framstaellning samt deras anvaendning som laekemedel.
FI922806A0 (fi)	1992-06-17	Substituerade 4-fenyl-4 -piperidinkarboxamider med baode lokalbedoevande och smaertstillande effekt samt foerfaranden foer deras framstaellning.
KR0148213B1 (en)	1998-08-17	Phenyla lkan(en)oic acid and pharmaceutical composition comprising the same
EP0423697A3 (en)	1992-08-05	Emulsion of lipid containing a prostaglandin analogue
DE3068379D1 (en)	1984-08-02	Indolobenzoxazines, processes for preparing and pharmaceutical compositions containing the same
GB2191695B (en)	1990-11-28	An ophthalmic pharmaceutical composition for cataract
NL300004I1 (nl)	2000-04-03	Voor de behandeling van oestrogeentekorten geschikte samenstelling.
AU8962882A (en)	1983-04-28	6-chloro 4-phenyl quinazoline derivatives
NO903338D0 (no)	1990-07-27	Fremgangsmaate for mikrobiologisk fremstilling av l-carnitin.
ATE100439T1 (de)	1994-02-15	2-(2-hydroxy-3-phenoxypropylamino)-ethoxybenzol derivate.
BE882594A (fr)	1980-07-31	Preparation des derives hydroxyles de l'isopropylamino-pyrimidine
DE3062787D1 (en)	1983-05-19	Novel process for the preparation of 6-aminopenicillanic acid-1,1-dioxide and its salts
MA19021A1 (fr)	1981-07-01	Procede de preparation de compositions pharmaceutiques a base d'alpha-12-bis(i methyl ethyl)amino/alpha-phenyl 2-pyridine acetamide ou de l'un de ses sels
HUT60927A (en)	1992-11-30	Process for producing pharmaceutical composition inhibiting the formation of activated lymphocytes
AU533275B2 (en)	1983-11-17	2-amino or 2-thio derivatives of 4,5-diphenyl-oxazole
JPS53116344A (en)	1978-10-11	Preparation of toluanilides
FR2694007B1 (fr)	1994-09-30	Nouveau procédé de préparation de composés stéroïdes 20-céto 21 (S) hydroxy et des intermédiaires.
DE68922596D1 (de)	1995-06-14	3-(3-Ethyl-1,2,4-oxadiazol-5-yl)-1-azabicycloheptan, Verfahren zu seiner Herstellung und dieses enthaltende pharmazeutische Zubereitungen.
JPS53137971A (en)	1978-12-01	Bis(iminodiacetaldehyde) derivatives and process for their preparation
JPS51141893A (en)	1976-12-07	Process for preparing 9-substituted-2-cycloalkylthioadenines.
JPS53105474A (en)	1978-09-13	2-alkoxybenzamides
GR860065B (en)	1986-04-30	Process for the preparation of aminophenol derivatives